The Business Research Company published its
Coronavirus (COVID-19) Current Therapy Global Market Report 2020 which provides
strategists, marketers and senior management with the critical information they
need to assess the global COVID-19 current therapy market. The report covers
the coronavirus (COVID-19) current therapy market’s segments- by drug type into
antiviral (remdesivir, ritonavir, lopinavir), antimalarial
(hydroxychloroquine), interferons (interferon beta), corticosteroid
(dexamethasone), others, and by end-use into hospitals, clinics, research
institutes, others.
View Complete Report: https://www.thebusinessresearchcompany.com/report/coronavirus-covid-19-current-therapy-market-global-report-2020-covid-19-growth-and-change
Coronavirus (COVID-19) Current Therapy Global Market Report 2020 is the most comprehensive report available on this market and will help gain a truly global perspective as it covers 60 geographies. The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by region and by country. It also compares the market’s historic and forecast growth. It covers all the regions, key developed countries and major emerging markets. It draws comparisons with country populations and economies to understand the importance of the market by country and how this is changing. The major regions included in the report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
Convalescent plasma therapy is being used
as an experimental therapy to treat COVID-19 patients. The blood plasma of
patients who have recovered from a disease is called convalescent plasma (CP).
CP therapy is a type of passive antibody therapy in which blood plasma is
isolated from patients who have recovered from the disease of interest and
administered to the patient with the severe disease in order to suppress the
virulence and improve clinical symptoms.
Few
Points From Table Of Content:
1. Executive Summary
2. Coronavirus (COVID-19) Current Therapy Market Characteristics
3. Coronavirus (COVID-19) Current Therapy Market Size And Growth
4. Coronavirus (COVID-19) Current Therapy Market Segmentation
5. Coronavirus (COVID-19) Current Therapy Market Regional And
Country Analysis
…...
26. Key Mergers And Acquisitions In The Coronavirus (COVID-19)
Current Therapy Market
27. Coronavirus (COVID-19) Current Therapy Market Trends And
Strategies
28. Coronavirus (COVID-19) Current Therapy Market Future Outlook and
Potential Analysis
29. Appendix
https://www.thebusinessresearchcompany.com/sample.aspx?id=3247&type=smp
Few Points from List Of Tables
Table 1: Global Historic Market Growth,
2015-2019, $ Billion
Table 2: Global Forecast Market Growth,
2015-2019, 2023F, 2025F, 2030F, $ Billion
Table 3: Global Coronavirus (COVID-19)
Current Therapy Market, Segmentation By Drug Type, Historic and Forecast,
2015-2019, 2023F, 2025F, 2030F, $ Billion
Table 4: Global Coronavirus (COVID-19)
Current Therapy Market, Segmentation By End User, Historic and Forecast,
2015-2019, 2023F, 2025F, 2030F, $ Billion
Table 5: Global Coronavirus (COVID-19)
Current Therapy Market, Split By Region, Historic and Forecast, 2015-2019,
2023F, 2025F, 2030F, $ Billion
………
Table 45: Moderna Therapeutics Financial
Performance
Table 46: Novavax Financial Performance
Table 47: Bravovax Financial Performance
Table 48: Ascletis Pharma Financial
Performance
Table 49: Altimmune Financial Performance
About
The Business Research Company:
The Business Research Company is a Business Intelligence Company
which excels in company, market and consumer research. It has offices in the
UK, the US and India and a network of trained researchers in 52 countries
globally.
Contact
Information:
The
Business Research Company
Europe:
+44 207 1930 708
Asia:
+91 8897263534
Americas:
+1 315 623 0293
Email:
info@tbrc.info
No comments:
Post a Comment